Stay updated on Apatinib Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apatinib Plus Pembrolizumab Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T16:34:09.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T03:45:38.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed descriptions of the study phases and inclusion criteria for a clinical trial involving apatinib and pembrolizumab, while retaining some core information about the trial's design and purpose.
    Difference
    49%
    Check dated 2025-04-16T14:25:31.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:16:42.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:50:29.000Z thumbnail image
  8. Check
    111 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:52:44.000Z thumbnail image

Stay in the know with updates to Apatinib Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.